新加坡银行业每月快讯 | 漫长和渐进式的复苏即将到来

 

8月份利率保持不变
三季度,3月期-SIBOR 和3月期-SOR分别稳定在0.41%和0.21%。然而,由于今年二季度报告的NIMs(净息差)处于历史低点,我们不太可能看到NIMs在未来的几个季度进一步下跌,因为银行通过重新定价和从资产负债表循环中剔除过剩的流动性来积极监控其利润率。

 
图1:3月期-SIBOR 和 SOR 保持稳定并接近历史低点

Source: Bloomberg, Company, PSR

 
图2:利率在2020年三季度保持稳定

Source: Bloomberg, PSR

 
 
图3:7月贷款增长略有回升

Source: MAS, PSR

 
7月贷款增长改善,但仍为负
贷款连续第二个月负增长,7月同比收缩0.3%。然而,商业贷款和消费贷款的数据均比6月份有所改善 (图3)。
7月,商业贷款同比增长1.48%,其中商业服务 (+21.7%),建筑(+4.9%),运输、仓储和通信(+3.6%)以及金融机构(+1.8%)扭转了观察到从农业、采矿和采石业(-23.4%),专业人士和个人(-8.9%),制造业(-4.6%),一般商业(-2.0%) 和其他行业 (4.3%)所带来的疲软。
观察到消费贷款继续全线疲软(同比下跌3.13%)。尽管如此,信用卡贷款环比增长了2%,在经历了连续五个月的萎缩后,已连续第二个月实现增长(图4)。 信用卡支出的增加可能会让银行的信用卡手续费收入有所复苏。

 
图4:自2019年12月以来,信用卡贷款连续两个月实现增长

Source: MAS, PSR

 
图5:7月贷款增长略有改善

 

Source: MAS, PSR

 
Fitch给出的‘负面评级观察’ (RNA) 并不是对银行业的担忧
8月31日,信用评级机构Fitch发表了一份报告,提出可能对三家本地银行下调至 ‘AA-’ 评级,令人担忧。
Fitch在其 “新加坡银行:有限的评级空间”报告中提到,较差的经营环境给各银行的盈利能力构成压力。这将导致“利润率变得更薄,信贷成本上升和信贷增长放缓”,进而可能会致使整个银行业的资本充足率恶化。
然而,这份RNA状态是自4月份发布的,而在报告中突显的较差的经济环境符合此前银行业提供的指引。因此,在经营环境没有发生任何根本改变的情况下,我们认为各银行的财务状况仍然是健康的。
 
证券成交量持续增长,而衍生品交易量保持波动。
初步的SDAV数据显示,8月份同比增长17%,从一年前的11.88亿新元增至13.86亿新元 (图6)。第三季度,证券业务持续增长。
然而,衍生品交易量仍不稳定。月度股指期货合约在前五大股指期货中占比95%以上的成交量,自7月录得同比增长27%后(图6),8月的成交量同比平均下降了12% (图7)。

 
图6:2020 SDAV 和DDAV 的表现

Source: SGX, Bloomberg, PSR

 
图7:前五大股指期货合约的成交量

 
富时台湾指数期货有望取代摩根士丹利资本国际台湾指数期货
新推出的富时台湾指数期货在8月录得超过350,000份交易合约。该合约成为新交所成交量第六大的股指期货,抵消了摩根士丹利资本国际台湾指数期货合约下降带来的影响,而旧合约将于2021年2月停止交易(图8)。
富时台湾指数期货作为摩根士丹利资本国际指数期货的同类替代品很受欢迎,这让我们相信,鉴于将推出更多的FTSE合约作为替代,那即将到期的MSCI合约将不会影响新交所的股票衍生品业务的前景。

 
投资行动
对新加坡银行业维持中性评级。虽然利率将继续拖累NIMs,但商业活动的恢复将提振非利息收入。我们仍然认为,银行已从今年二季度的盈利打击中,进入一个逐渐复苏的时期。

 

如果有想了解更多全球股市资讯,请关注微信公众号 “辉立资本新加坡” (SGPSPL)。同时提供在线免费开设股票账户,一个账户轻松交易全球股票和ETF

美股,港股,新加坡股,中国A股,越南股票,韩国股票,德国股票,马来西亚股票,泰国股票,印尼股票,菲律宾股票,日本股票,澳大利亚股票,台湾股票,加拿大股票,英国股票,法国股票,荷兰股票,葡萄牙股票,比利时股票,土耳其股票

如果本文是英文翻译版本,一切请以英文为准

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com